Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Palvanil is an agonist of transient receptor potential vanilloid 1 (TRPV1) and a derivative of capsaicin (Item Nos. 92350 | 10010743).1 It increases intracellular calcium levels in HEK293 cells expressing human TRPV1 (EC50 = 5 nM). Palvanil also selectively binds to the cannabinoid 1 (CB1) receptor over the CB2 receptor (Kis = 3 and >15 µM, respectively).2 Unlike olvanil (Item No. 90262) and arvanil (Item No. 90052), palvanil does not inhibit anandamide (arachidonoyl ethanolamide; Item No. 90050) transport into RBL-2H3 cells (IC50 = >50 µM). Palvanil inhibits the proliferation of MCF-7, EFM-19, and T47D breast cancer cells (IC50s = 2.2, 1, and 1.6 µM, respectively). It increases whole gastrointestinal (GI) transit time in mice and has antinociceptive activity in a mouse model of visceral pain at 1 mg/kg.3 Palvanil (0.05 and 0.1 mg/kg) also decreases immobility time in the forced swim test in rats.4
WARNING This product is not for human or veterinary use.
1. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: Inhibitors of anandamide uptake with negligible capsaicin-
2. Unsaturated long-
3. Desensitization of transient receptor potential vanilloid type-
4. Capsaicin produces antidepressant-